NxThera Completes $12.6 Million in Series B Financing for Treating BPH
NxThera Inc., a St. Paul, Minn.-based privately held medical devices company, has added $12.6 million in Series B financing.
Month: March 2011
RealBio Technology Transforms Research & Pharmaceutical Testing
RealBio’s technology allows cells grown in a laboratory setting to develop as they would in a normal human body.
Sonitus Medical Obtains European Mark For Premier Hearing Prosthetic Of It’s Kind
Sonitus Medical, Inc., a medical device company that manufactures the world’s first non-surgical and removable hearing prosthetic to transmit sound via the teeth, recently announced that it has received CE Mark certification.
S.E.A. Medical Systems Welcomes New Board Members
S.E.A. Medical Systems, Inc., a privately held medical device company dedicated to making intravenous drug delivery safer for patients, recently welcomed two additions to their Board of Directors.
CoaguSense Develops Anticoagulation apparatus to Detect Blood Clot formation
CoaguSense is a medical device company that has developed an anticoagulation monitoring apparatus for individuals at risk for thrombosis, an adverse blood clot formation that […]
First Light Uses MultiPath Technology to Prevent Hospital Infections
First Light Biosciences is a development stage company developing novel medical diagnostic products for preventing and detecting healthcare associated infections. The company’s MultiPath technology, which […]
ThromboVision Uses Light Scattering Technology to Avoid Blood Clots
ThromboVision is a medical devices company that has developed a technological platform to determine an individual’s susceptibility to thrombosis, an adverse blood clot formation that […]
Sphere Medical Develops Innovative Monitoring Platform
Sphere Medical is a medical device company that has developed a technological platform for the development of advanced physiological monitoring devices, including apparatuses for use […]
Molecular Diagnostics and the Changing Landscape: Considerations and Implications
Wednesday, March 23 – Thursday, March 24, 2011 Washington, DC Metro Area The Liaison Capitol Hill 415 New Jersey Avenue, NW Washington, DC 20001 Molecular […]
2B Blackbio Obtains CE Marking for Identifying Fungal Infections
2B Blackbio, dedicated to developing and marketing new solutions for personalized medicine, has obtained CE Marking for BlackLight Fungal ID Kit, intended for a fast and easy‐to‐use diagnostic test, allowing rapid identification of fungal infections.